Single Low-Dose Nanovaccine for Long-Term Protection against Anthrax Toxins.
Sign Up to like & getrecommendations! Published in 2022 at "Nano letters"
DOI: 10.1021/acs.nanolett.2c03881
Abstract: Anthrax infections caused by Bacillus anthracis are an ongoing bioterrorism and livestock threat worldwide. Current approaches for management, including extended passive antibody transfusion, antibiotics, and prophylactic vaccination, are often cumbersome and associated with low patient… read more here.
Keywords: single low; anthrax toxins; nanovaccine long; anthrax ... See more keywords
Antibodies against Anthrax Toxins: A Long Way from Benchlab to the Bedside
Sign Up to like & getrecommendations! Published in 2022 at "Toxins"
DOI: 10.3390/toxins14030172
Abstract: Anthrax is an acute disease caused by the bacterium Bacillus anthracis, and is a potential biowarfare/bioterrorist agent. Its pulmonary form, caused by inhalation of the spores, is highly lethal and is mainly related to injury… read more here.
Keywords: antibodies anthrax; development; anthrax toxins; toxins long ... See more keywords